September is Prostate Cancer Awareness Month.
From testing men throughout the country to holding fundraising events, ZERO -
The Project to End Prostate Cancer works to bring prostate cancer to the forefront
of the cancer community.
Now is the time to get involved with the prostate cancer cause as ZERO works to raise
awareness about the disease and fights to end it.
LifeScience Moment: The Hatch-Waxman Act was passed to encourage development of generic prescription drugs."
On September 24, 1984 the Hatch-Waxman Act (Drug Price Competition and Patent Term Restoration Act) was passed to encourage development of
generic prescription drugs.
The Act, named for its sponsors, Representative Henry Waxman of California and Senator Orrin Hatch of Utah, established a process
whereby marketers of generic drugs can file Abbreviated New Drug Applications (ANDAs) to seek FDA approval of the generic; allows 180 day
exclusivity to companies that are the "first-to-file" an ANDA against holders of patents for branded counterparts; and streamlined the process
for approving generic drugs by requiring only that manufacturers demonstrate "bioequivalence" to an already approved innovator drug.
It's a Small World
"A fool's brain digests philosophy into folly, science into superstition, and art into pedantry. Hence University education."
George Bernard Shaw, Irish dramatist